Endogenous hormones, participant characteristics, and symptoms among midlife women

Maturitas

Volumn 59, Issue 2, 2008, Pages 114-127

  Gallicchio, Lisa ^a,b   Schilling, Chrissy ^b   Romani, William A ^c   Miller, Susan ^d   Zacur, Howard ^d   Flaws, Jodi A ^e  

^a MERCY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Androgens; Estrogens; Incontinence; Insomnia; Menopausal transition; Midlife; Sleep; Symptoms

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ESTRADIOL; ESTROGEN; ESTRONE; HORMONE; PRASTERONE SULFATE; PROGESTERONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTICLE; BLOOD SAMPLING; CLIMACTERIUM; CONFIDENCE INTERVAL; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEADACHE; HOT FLUSH; HUMAN; INCONTINENCE; INSOMNIA; IRRITABILITY; LIFESTYLE; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; QUESTIONNAIRE; VAGINA DISCHARGE; VAGINA DISEASE; VAGINA DRYNESS; VISUAL DISORDER;

ANDROGENS; CROSS-SECTIONAL STUDIES; ESTROGENS; FEMALE; HUMANS; LIFE STYLE; LOGISTIC MODELS; MENOPAUSE; MIDDLE AGED; ODDS RATIO; PREVALENCE; SEX HORMONE-BINDING GLOBULIN; SLEEP INITIATION AND MAINTENANCE DISORDERS; VISION DISORDERS;

EID: 40249104562     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.01.003     Document Type: Article

References (43)

1. Bankowski B.J., Gallicchio L.M., Whiteman M.K., Lewis L.M., Zacur H.A., and Flaws J.A. The association between menopausal symptoms and quality of life in midlife women. Fertil Steril 86 (2006) 1006-1008
2. Woods N.F., and Mitchell E.S. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med 118 (2005) 14S-24S
3. Schwingl P.J., Hulka B.S., and Harlow S.D. Risk factors for menopausal hot flashes. Obstet Gynecol 84 (1994) 29-34
4. Dennerstein L., Dudley E.C., Hopper J.L., Guthrie J.R., and Burger H.G. A prospective population-based study of menopausal symptoms. Obstet Gynecol 93 (2000) 351-358
5. Freeman E.W., Sammel M.D., Lin H., et al. Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol 110 (2007) 230-240
6. Freeman E.W., Sammel M.D., Lin H., Gracia C.R., Kapoor S., and Ferdousi T. The role of anxiety and hormonal changes in menopausal hot flashes. Menopause 12 (2005) 258-266
7. Guthrie J.R., Dennerstein L., Taffe J.R., and Donnelly V. Health care-seeking for menopausal problems. Climacteric 6 (2003) 112-117
8. Visvanathan K., Gallicchio L., Schilling C., et al. Cytochrome gene polymorphisms, serum estrogens, and hot flushes in midlife women. Obstet Gynecol 106 (2005) 1372-1381
9. Erlik Y., Meldrum D.R., and Judd H.L. Estrogen levels in postmenopausal women with hot flashes. Obstet Gynecol 59 (1982) 403-407
10. McCoy N., Culter W., and Davidson J.M. Relationships among sexual behavior, hot flashes, and hormone levels in perimenopausal women. Arch Sex Behav 14 (1985) 385-394
11. Guthrie J.R., Dennerstein L., Hopper J.L., and Burger H.G. Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women. Obstet Gynecol 88 (1996) 437-442
12. Wilbur J., Miller A.M., Montgomery A., and Chandler P. Sociodemographic characteristics, biological factors, and symptom reporting in midlife women. Menopause 5 (1998) 43-51
13. Overlie I., Moen M.H., Holte A., and Finset A. Androgens and estrogens in relation to hot flushes during the menopausal transition. Maturitas 41 (2002) 69-77
14. Hollander L.E., Freeman E.W., Sammel M.D., Berlin J.A., Grisso J.A., and Battistini M. Sleep quality, estradiol levels, and behavioral factors in late reproductive age women. Obstet Gynecol 98 (2001) 391-397
15. Kravitz H.M., Janssen I., Santoro N., et al. Relationship of day-to-day reproductive hormone levels to sleep in midlife women. Arch Intern Med 165 (2005) 2370-2376
16. Gallicchio L., Miller S.R., Visvanathan K., et al. Cigarette smoking, estrogen levels, and hot flashes in midlife women. Maturitas 53 (2006) 133-143
17. Bao A.M., Liu R.Y., Van Someren E.J., Hofman M.A., Cao Y.X., and Zhou J.N. Diurnal rhythm of free estradiol during the menstrual cycle. Eur J Endocrinol 148 (2003) 227-232
18. Vermeulen A. The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab 42 (1976) 247-253
19. Whiteman M.K., Staropoli C.A., Langenberg P., McCarter R.J., Kjerulff K.H., and Flaws J.A. Smoking, body mass, and hot flashes in midlife women. Obstet Gynecol 101 (2003) 264-272
20. Gallicchio L., Visvanathan K., Miller S.R., et al. Body mass, estrogen levels, and hot flashes in midlife women. Am J Obstet Gynecol 193 (2005) 1353-1360
21. Sowers M.R., Finkelstein J.S., Ettinger B., et al. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN. Osteoporos Int 14 (2003) 44-52
22. Benyamini Y., and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57 (1995) 289-300
23. Dennerstein L., Lehert P., Burger H.G., and Guthrie J.R. New findings from non-linear longitudinal modelling of menopausal hormone changes. Hum Reprod Update 13 (2007) 551-557
24. Woods N.F., Smith-Dijulio K., Percival D.B., Tao E.Y., Taylor H.J., and Mitchell E.S. Symptoms during the menopausal transition and early postmenopause and their relation to endocrine levels over time: observations from the Seattle Midlife Women's Health Study. J Womens Health (Larchmt) 16 (2007) 667-677
25. Randolph Jr. J.F., Sowers M., Bondarenko I., et al. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. J Clin Endocrinol Metab 90 (2005) 6106-6112
26. Smith M.J., Adams L.F., Schmidt P.J., Rubinow D.R., and Wassermann E.M. Effects of ovarian hormones on human cortical excitability. Ann Neurol 51 (2002) 599-603
27. Inghilleri M., Conte A., Curra A., Frasca V., Lorenzano C., and Berardelli A. Ovarian hormones and cortical excitability. An rTMS study in humans. Clin Neurophysiol 115 (2004) 1063-1068
28. Ford K., Sowers M., Crutchfield M., Wilson A., and Jannausch M. A longitudinal study of the predictors of prevalence and severity of symptoms commonly associated with menopause. Menopause 12 (2005) 308-317
29. Weiss G., Skurnick J.H., Goldsmith L.T., Santoro N.F., and Park S.J. Menopause and hypothalamic-pituitary sensitivity to estrogen. JAMA 292 (2004) 2991-2996
30. Freeman E.E., Munoz B., Schein O.D., and West S.K. Hormone replacement therapy and lens opacities: the Salisbury Eye Evaluation project. Arch Ophthalmol 119 (2001) 1687-1692
31. Defay R., Pinchinat S., Lumbrosos S., et al. Relationship between hormonal status and cataract in French postmenopausal women: the POLA Study. Ann Epidemiol 13 (2003) 634-644
32. Klein B.E., Klein R., and Ritter L.L. Is there evidence of an estrogen effect on age-related lens opacities? The Beaver Dam Eye Study. Arch Ophthalmol 112 (1994) 85-91
33. Klein B.E., Klein R., and Lee K.E. Reproductive exposures, incident age-related cataracts, and age-related maculopathy in women: the beaver dam eye study. Am J Ophthalmol 130 (2000) 322-326
34. Cumming R.G., and Mitchell P. Hormone replacement therapy, reproductive factors, and cataract. The Blue Mountains Eye Study. Am J Epidemiol 145 (1997) 242-249
35. Benitez del Castillo J.M., del R.T., and Garcia-Sanchez J. Effects of estrogen use on lens transmittance in postmenopausal women. Ophthalmology 104 (1997) 970-973
36. Younan C., Mitchell P., Cumming R.G., Panchapakesan J., Rochtchina E., and Hales A.M. Hormone replacement therapy, reproductive factors, and the incidence of cataract and cataract surgery: the Blue Mountains Eye Study. Am J Epidemiol 155 (2002) 997-1006
37. Worzala K., Hiller R., Sperduto R.D., et al. Postmenopausal estrogen use, type of menopause, and lens opacities: the Framingham studies. Arch Intern Med 161 (2001) 1448-1454
38. Eisner A., Toomey M.D., Falardeau J., Samples J.R., and Vetto J.T. Differential effects of tamoxifen and anastrozole on optic cup size in breast cancer survivors. Breast Cancer Res Treat 106 (2007) 161-170
39. Metka M., Enzelsberger H., Knogler W., Schurz B., and Aichmair H. Ophthalmic complaints as a climacteric symptom. Maturitas 14 (1991) 3-8
40. Holtedahl K., Hunskaar S., and Prevalence. 1-year incidence and factors associated with urinary incontinence: a population based study of women 50-74 years of age in primary care. Maturitas 28 (1998) 205-211
41. Dallosso H.M., McGrother C.W., Matthews R.J., and Donaldson M.M. The association of diet and other lifestyle factors with overactive bladder and stress incontinence: a longitudinal study in women. BJU Int 92 (2003) 69-77
42. Garcia-Closas M., Herbstman J., Schiffman M., Glass A., and Dorgan J.F. Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre-menopausal women. Int J Cancer 102 (2002) 172-178
43. Soules M.R., Sherman S., Parrott E., et al. Stages of Reproductive Aging Workshop (STRAW). J Womens Health Gend Based Med 10 (2001) 843-848